INmune Bio and Quantum Computing partner to apply quantum optimization and AI to advance Alzheimer’s drug research and explore new applications for XPro

Boca Raton, Florida, October 14th, 2026, Financewire Collaboration combines INmune Bio’s clinical research with QCi’s Dirac-3S quantum optimization machine to identify potential new treatment indications and biomarkers for XPro. Initial engagement marks QCi’s first commercial customer in pharmaceutical and biotechnology markets, expanding the application of quantum computing to drug development. INmune Bio Inc. (Nasdaq: INMB) […] This story continues at The Next Web

Read it at The Next Web ↗

← Front page